As people contemplate their choices for managing appendicitis — antibiotics or surgery — the data from this UCLA research can help ensure they make a fully informed choice.
“We now have a rational and logical way to develop immunotherapies going forward and a clinical development process for doing it,” said UCLA's Dr. Timothy Cloughesy.
The driving force behind the development of Herceptin will split a $1 million prize from the Royal Swedish Academy of Sciences and the Sjöberg Foundation.
The comedian, actor, director, writer and producer, who died in March 2016, directed funds to benefit research in endocrinology, diabetes and hypertension; infectious diseases; and pancreatic diseases.
Q&A with Melissa Reider-Demer who was honored by the health care organization Press Ganey, which promotes clinical safety, patient experience and workforce engagement.
En 2010 y 2011, 8,943 hombres de 15 a 50 años de edad en Chihuahua fueron asesinados: tres veces el número de muertes entre las tropas de los Estados Unidos en Irak desde 2003 y 2006.
A technique they developed coaxes pluripotent stem cells — which can can be grown indefinitely in the lab — into becoming mature T cells capable of killing tumor cells.